These methods showed that the disruptive effects of different agents on OLIG2 dimerization correlated with the inhibitory effects of these agents on in vitro tumor cell growth [21, 22], supporting the proposed mechanism of action of these agents and the specificity of their anti-tumor effect. The gene discussed is OLIG2; the disease is neoplasm.